Clinical Trials Map
The results of clinical trials suggest that psychedelics could be used for a range of therapeutic purposes, but figuring out how to participate in psychedelic-assisted therapy as either a therapist or a patient can be complicated. BCSP’s clinical trials map, featuring data from ClinicalTrials.gov, provides a way to navigate past, ongoing and future trials.
Trifecta Research Study
Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Scottsdale Research InstitutePhoenix, Arizona, United States
Behavioral Research Specialists, LLCGlendale, California, United States
Kadima Neuropsychiatry InstituteLa Jolla, California, United States
TRIP Clinic and Psychedelic Science InstituteLos Angeles, California, United States
CalNeuro Research GroupLos Angeles, California, United States
Lipov Medical GroupLos Angeles, California, United States
Excell Research, IncOceanside, California, United States
Open Mind Collective / UCSF Medical Center – Mount ZionSan Francisco, California, United States
Inland Psychiatric Medical Group Inc (IPMG Research)San Juan Capistrano, California, United States
Mountain View Clinical ResearchDenver, Colorado, United States
Starlight Clinical ResearchEvergreen, Colorado, United States
Research Centers of AmericaHollywood, Florida, United States
Clinical Neuroscience SolutionsJacksonville, Florida, United States
K2 Medical ResearchLady Lake, Florida, United States
Segal Trials Center for Psychedelic ResearchLauderhill, Florida, United States
Accel Research Sites – MaitlandMaitland, Florida, United States
K2 Medical ResearchMaitland, Florida, United States
Clinical Neuroscience Solutions, IncOrlando, Florida, United States
Charter ResearchOrlando, Florida, United States
Combined Research Orlando Phase I-IVOrlando, Florida, United States
Cenexel iResearcvh Atlanta, LLCAtlanta, Georgia, United States
Atlanta Center For Medical ResearchAtlanta, Georgia, United States
CenExel iResearchSavannah, Georgia, United States
Uptown Research InstituteChicago, Illinois, United States
Psychiatric Medicine Associates, LLCSkokie, Illinois, United States
Psychiatric Medicine AssociatesSkokie, Illinois, United States
Sunstone Medical, PCRockville, Maryland, United States
Adams Clinical BostonBoston, Massachusetts, United States
Elixia HealthSpringfield, Massachusetts, United States
Adams ClinicalWatertown, Massachusetts, United States
Institute for Integrative TherapiesEden Prairie, Minnesota, United States
Redbird ResearchLas Vegas, Nevada, United States
Global Medical Institutes, Princeton Medical InstitutePrinceton, New Jersey, United States
Bio Behavioral HealthToms River, New Jersey, United States
Adams Clinical HarlemNew York, New York, United States
Adams Clinical BronxThe Bronx, New York, United States
Neurobehavioral Clinical ResearchCanton, Ohio, United States
Adams Clinical PhiladelphiaPhiladelphia, Pennsylvania, United States
Clinical Neuroscience Solutions, CNS HealthcareMemphis, Tennessee, United States
Adams Clinical DallasDeSoto, Texas, United States
Zillan Clinical ResearchHouston, Texas, United States
Cedar Clinical ResearchDraper, Utah, United States
Thompson Brain & Mind HealthcareMaroochydore, Queensland, Australia
Ramsay ClinicMelbourne, Victoria, Australia
Monash University – Notting HillNotting Hill, Victoria, Australia
Eginition Hospital, First Department of Psychiatry of the National and Kapodistrian University of Athens (NKUA)Athens, Greece
Aristotle University of TessalonikiThessaloniki, Greece
Promente – Centrum Neurologii i Psychogeriatrii w BydgoszczyBydgoszcz, Poland
Ascend Clinical ResearchReading, United Kingdom
Psilocybin for Methamphetamine Use Disorder
University of Alabama at BirminghamBirmingham, Alabama, United States
Ketamine Treatment for Treatment-Resistant Depression – the Role of Framing
Brain Stimulation Clinic, Skaraborg's HospitalSkövde, Västra Götaland County, Sweden
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
University of California San Francisco (UCSF) Department of NeurologySan Francisco, California, United States
University of Colorado Anschutz Medical CampusAurora, Colorado, United States
Emory University Brain Health CenterAtlanta, Georgia, United States
Dana-Farber Cancer InstituteBoston, Massachusetts, United States
University of Nebraska Medical CenterOmaha, Nebraska, United States
New York University Langone Health, Center for Psychedelic MedicineNew York, New York, United States
PRoMiSS: Psilocybin and the Role of Music in Set and Setting
Center for Psychedelics and Consciousness Research in the Behavioral Biology Research CenterBaltimore, Maryland, United States
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
Djavad Mowafaghian Centre for Brain HealthVancouver, British Columbia, Canada
Department of Psychiatry, University of Ottawa, The Ottawa HospitalOttawa, Ontario, Canada
Department of Psychiatry, University of Toronto, University Health Network,Toronto, Ontario, Canada
Psilocybin Administration With 5-HT1a Blockade
Center for Psychedelics and Consciousness ResearchBaltimore, Maryland, United States
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
Brown University School of Public HealthProvidence, Rhode Island, United States
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Connecticut Mental Health CenterNew Haven, Connecticut, United States
Page 1 of 18
How to use the clinical trials map
Clinical trials have provided growing evidence that ketamine, psilocybin, and MDMA can work in combination with therapy to help alleviate a range of mental disorders, including PTSD, depression, substance-use disorders, and anxiety. The field is advancing rapidly, but it can be difficult to navigate changing information to learn more about specific trials.
In the map view, explore clinical trials based on location. Click on a pink cluster or use the + button to zoom in on a particular location. Click on a smaller pink dot to access an overview of a particular clinical trial, including the substance, the phase, and relevant conditions. Click on the “Full Trial Record” link to learn more about the trial on the ClinicalTrials.gov site.
In the list view, the clinical trials tracker offers a tool for researchers and clinicians to quantify and explore trials based on a number of factors. Click on “Filter” to see relevant trials based on substance, trial status, study phase and more. Where the list shows closed trials users are able explore published results, including searching by institution.